INO:NASDAQ
Inovio Pharmaceuticals Inc
1,01 USD
arrow_upward
+1,00%(+0,0100) 1D
1,07 USD
arrow_upward
+5,93% (+0,060)bedtimeAfter hours
Closed: 20-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,01 USD
High
1,06 USD
Low
0,99 USD
Mkt. cap
104,43 млн
Avg. vol.
2,85 млн
Volume
7,95 млн
52-wk high
2,72 USD
52-wk low
0,56 USD
EPS
-1,17 USD
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
Open
1,01 USD
High
1,06 USD
Low
0,99 USD
Mkt. cap
104,43 млн
Avg. vol.
2,85 млн
Volume
7,95 млн
52-wk high
2,72 USD
52-wk low
0,56 USD
EPS
-1,17 USD
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
Investing.com UK
·
28 мүнөт мурун
Inovio secures $80.4 million judgment against VGXI, GeneOne By Investing.com
PR Newswire
·
37 мүнөт мурун
INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc